Skip to main content
Clinical Trials/NCT02944292
NCT02944292
Unknown
Phase 4

Prospective, Interventional Multicentre Study on the Effect of Deepening of Sedation on Intra-abdominal Pressure

Tartu University Hospital1 site in 1 country40 target enrollmentNovember 2016

Overview

Phase
Phase 4
Intervention
Deepening of sedation
Conditions
Intra-abdominal Hypertension
Sponsor
Tartu University Hospital
Enrollment
40
Locations
1
Primary Endpoint
Intra-abdominal pressure
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effect of deepening of sedation on intra-abdominal pressure in mechanically ventilated adult patients with intra-abdominal hypertension.

Detailed Description

The importance of intra-abdominal pressure (IAP) in critically ill patients has been addressed increasingly. Several studies have shown that elevated mean IAP is associated with adverse ICU outcomes. The prevalence of intra-abdominal hypertension (IAH) among critically ill patients is as high as 50% if defined according to maximal IAP and half of it if defined according to mean IAP. Development of IAH during ICU period is an independent risk factor for death. Considering such significant impact on patients' outcome, international conference of experts has agreed and published recommendations for treatment of IAH and abdominal compartment syndrome. Among others, deepening of sedation is suggested as treatment option. The recommendation is based on expert opinion; there are no controlled clinical studies available to support this approach. Importantly, recent studies have shown that deep sedation itself may be associated with worse outcome to patients. Treggiari et al suggest that a strategy of light sedation affords benefits with regard to reduction of intensive care unit stay and duration of ventilation without negatively affecting subsequent patient mental health or patient safety. Others have shown reduced ICU mortality as well as reduced incidence of ventilator-associated pneumonia in conjunction with light sedation. This is a prospective, interventional, multicentre study. There will be no control group. Study subjects: Adult, mechanically ventilated patients with IAP between 12 and 20 mmHg in at least two consecutive measurements, spontaneous breathing activity of at least 6 breaths/minute, RASS score between 0 and -4, if no contraindications to propofol administration are present and no other interventions to reduce IAP are planned. Study intervention: Sedation deepening will be achieved with a bolus of propofol 1 mg/kg followed by continuous infusion of propofol 3 mg/kg/h for one hour. Patients previously receiving propofol infusion will receive supplemental propofol per protocol up to a maximum infusion rate of 5 mg/kg/h. Series of measurements of IAP will be performed before (once) and after (repeatedly) intervention (deepening of sedation). Deepness of sedation will be assessed with RASS score.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
December 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joel Starkopf

Professor of Anaesthesiology and Intensive Care

Tartu University Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Mechanical ventilation
  • IAP between 12 and 20 mmHg in at least two consecutive measurements within 1-12 h
  • Spontaneous breathing activity of at least 6 breaths/minute
  • RASS score between 0 and -4
  • Physician-led sedation (if sedated; as opposed to nurse-led protocol)

Exclusion Criteria

  • Contraindication for propofol administration
  • Contraindication for IAP measurement in supine position with head-of-bed at 0°
  • Other intervention for reduction of IAP planned
  • Previous propofol infusion rate \>4 mg/kg/h

Arms & Interventions

All enrolled patients

Study population: Adult, mechanically ventilated patients with IAP between 12 and 20 mmHg in at least two consecutive measurements, spontaneous breathing activity of at least 6 breaths/minute, RASS score between 0 and -4, if no contraindications to propofol administration are present and no other immediate interventions to reduce IAP are planned Intervention: Deepening of sedation Deepening of sedation will be achieved with a bolus of propofol followed by continuous infusion for one hour.

Intervention: Deepening of sedation

All enrolled patients

Study population: Adult, mechanically ventilated patients with IAP between 12 and 20 mmHg in at least two consecutive measurements, spontaneous breathing activity of at least 6 breaths/minute, RASS score between 0 and -4, if no contraindications to propofol administration are present and no other immediate interventions to reduce IAP are planned Intervention: Deepening of sedation Deepening of sedation will be achieved with a bolus of propofol followed by continuous infusion for one hour.

Intervention: Propofol

Outcomes

Primary Outcomes

Intra-abdominal pressure

Time Frame: At 30 minutes after the start of deepening of sedation (propofol bolus)

Secondary Outcomes

  • Mean arterial pressure(After sedative bolus; at 1) 15, 2) 30, 3) 60 minutes after starting the continuous infusion of propofol)
  • Intra-abdominal pressure(After sedative bolus; at 1) 15, 2) 30, 3) 60 minutes after starting the continuous infusion of propofol)
  • Spontaneous and total respiratory rate(After sedative bolus; at 1) 15, 2) 30, 3) 60 minutes after starting the continuous infusion of propofol)
  • Abdominal perfusion pressure(After sedative bolus; at 1) 15, 2) 30, 3) 60 minutes after starting the continuous infusion of propofol)
  • Richmond Agitation-Sedation Scale(After sedative bolus; at 1) 15, 2) 30, 3) 60 minutes after starting the continuous infusion of propofol)
  • Tidal volume(After sedative bolus; at 1) 15, 2) 30, 3) 60 minutes after starting the continuous infusion of propofol)
  • PEEP, Ppeak, Pplat(After sedative bolus; at 1) 15, 2) 30, 3) 60 minutes after starting the continuous infusion of propofol)
  • Total number of vasopressor and inotrope boluses(During the intervention)
  • Maximal increase in dose of noradrenaline(During the intervention)

Study Sites (1)

Loading locations...

Similar Trials

Effect of Sedation on Intra-abdominal... | Clinical Trial